...A. The shareholder list shows that as of the record date there were 496,458,384 shares of common stock outstanding and entitled to vote at this meeting. B. Elanco closed 2024 with strength as the business improved, increasing full year organic constant currency revenue growth to 3%. C. That momentum is accelerating into 2025 with first quarter organic constant currency revenue growth of 4%, with additional step up to mid-single digits expected for the full year of 2025. D. Our strategy is working with seven consecutive quarters of top line growth and progress against our three key priorities growth, innovation, and cash. E. Revenue from innovation is exceeding expectations, and we've raised 2025 innovation guidance to $660 million to $740 million. F. In addition, our base business is stabilizing as we see innovation drive further adoption of our complete portfolio of solutions. G. Our discipline focus on cash generation delivered $540 million in operating cash flow in 2024, a significant...
